Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Candida albicans delays HIV-1 replication in macrophages.

Rodriguez Rodrigues C, Remes Lenicov F, Jancic C, Sabatté J, Cabrini M, Ceballos A, Merlotti A, Gonzalez H, Ostrowski M, Geffner J.

PLoS One. 2013 Aug 23;8(8):e72814. doi: 10.1371/journal.pone.0072814.

2.

Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.

Xiang J, George SL, Wünschmann S, Chang Q, Klinzman D, Stapleton JT.

Lancet. 2004 Jun 19;363(9426):2040-6.

PMID:
15207954
3.
4.

Is decreased HIV-1 infectivity of placental macrophages caused by high levels of beta-chemokines?

Meléndez J, García V, Sánchez E, Delgado R, Torres G, Meléndez-Guerrero LM.

Cell Mol Biol (Noisy-le-grand). 2001;47 Online Pub:OL51-9.

PMID:
11936874
5.

Soluble CD40 ligand induces beta-chemokine production by macrophages and resistance to HIV-1 entry.

di Marzio P, Mariani R, Lui R, Thomas EK, Landau NR.

Cytokine. 2000 Oct;12(10):1489-95.

PMID:
11023663
6.

Macrophage-tropic HIV induces and exploits dendritic cell chemotaxis.

Lin CL, Sewell AK, Gao GF, Whelan KT, Phillips RE, Austyn JM.

J Exp Med. 2000 Aug 21;192(4):587-94.

7.

Inhibition of HIV type 1 BaL replication by MIP-1alpha, MIP-1beta, and RANTES in macrophages.

Capobianchi MR, Abbate I, Antonelli G, Turriziani O, Dolei A, Dianzani F.

AIDS Res Hum Retroviruses. 1998 Feb 10;14(3):233-40.

PMID:
9491913
8.

Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection.

Gross E, Amella CA, Pompucci L, Franchin G, Sherry B, Schmidtmayerova H.

J Leukoc Biol. 2003 Nov;74(5):781-90.

PMID:
12960233
9.

Limited expression of R5-tropic HIV-1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1alpha, and MIP-1beta.

Annunziato F, Galli G, Nappi F, Cosmi L, Manetti R, Maggi E, Ensoli B, Romagnani S.

Blood. 2000 Feb 15;95(4):1167-74.

10.

Activation of Toll-like receptor 2 increases macrophage resistance to HIV-1 infection.

Victoria S, Temerozo JR, Gobbo L, Pimenta-Inada HK, Bou-Habib DC.

Immunobiology. 2013 Dec;218(12):1529-36. doi: 10.1016/j.imbio.2013.06.006.

PMID:
23891328
11.

CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages.

Moriuchi H, Moriuchi M, Combadiere C, Murphy PM, Fauci AS.

Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15341-5.

12.

Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.

Trkola A, Paxton WA, Monard SP, Hoxie JA, Siani MA, Thompson DA, Wu L, Mackay CR, Horuk R, Moore JP.

J Virol. 1998 Jan;72(1):396-404.

13.
14.

Interaction of human immunodeficiency virus type 1 envelope glycoprotein V3 loop with CCR5 and CD4 at the membrane of human primary macrophages.

Rabehi L, Seddiki N, Benjouad A, Gluckman JC, Gattegno L.

AIDS Res Hum Retroviruses. 1998 Dec 20;14(18):1605-15. Erratum in: AIDS Res Hum Retroviruses 1999 Mar 20;15(5):493.

PMID:
9870313
15.

Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophages.

Worgall S, Connor R, Kaner RJ, Fenamore E, Sheridan K, Singh R, Crystal RG.

J Virol. 1999 Jul;73(7):5865-74.

17.

Macrophage inflammatory protein-1alpha is induced by human immunodeficiency virus infection of monocyte-derived macrophages.

Canque B, Rosenzwajg M, Gey A, Tartour E, Fridman WH, Gluckman JC.

Blood. 1996 Mar 1;87(5):2011-9.

18.

Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.

Walker WE, Kurscheid S, Joshi S, Lopez CA, Goh G, Choi M, Barakat L, Francis J, Fisher A, Kozal M, Zapata H, Shaw A, Lifton R, Sutton RE, Fikrig E.

J Virol. 2015 May;89(10):5502-14. doi: 10.1128/JVI.00118-15.

19.

Inhibition of HIV-1 replication in human monocyte-derived macrophages by parasite Trypanosoma cruzi.

Andreani G, Celentano AM, Solana ME, Cazorla SI, Malchiodi EL, Martínez Peralta LA, Dolcini GL.

PLoS One. 2009 Dec 14;4(12):e8246. doi: 10.1371/journal.pone.0008246.

20.

Advanced glycation end products inhibit both infection and transmission in trans of HIV-1 from monocyte-derived dendritic cells to autologous T cells.

Nasreddine N, Borde C, Gozlan J, Bélec L, Maréchal V, Hocini H.

J Immunol. 2011 May 15;186(10):5687-95. doi: 10.4049/jimmunol.0902517.

Supplemental Content

Support Center